Breaking News
Get 45% Off 0
🤯 +96%, +62%, +40%: These AI-picked stocks are soaring!
See the list

Amazon On The Brink Of EHR Deal With Cerner

By Zacks Investment ResearchStock MarketsNov 29, 2017 03:45AM ET
www.investing.com/analysis/amazon-on-the-brink-of-ehr-deal-with-cerner-200269203
Amazon On The Brink Of EHR Deal With Cerner
By Zacks Investment Research   |  Nov 29, 2017 03:45AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
-0.14%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MSFT
-0.50%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GOOGL
-0.02%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AAPL
+0.05%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AMZN
-1.63%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MCK
+0.43%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Amazon (NASDAQ:AMZN) is on the brink of a major healthcare/machine learning deal with Cerner (NASDAQ:CERN) , according to CNBC. This isn’t the first time that the company has partnered with the leading EHR provider. In the past, Cerner has used AWS for storage, computer networking and databases and for on-demand disaster recovery.

What’s Changed Now?

Cerner’s HealtheIntent platform facilitates the gathering and retrieval of and access to patient electronic records (EHRs) including prescriptions to facilitate their analysis by hospitals and healthcare professionals, thereby reducing the cost and improving upon the outcome of treatment while also taking care of insurance claims. Through Amazon’s AWS platform, Cerner intends to deliver these services along with Amazon’s advanced analytics at greater speeds to large healthcare organizations that operate on a bigger scale and across geographies.

Amazon Has The Capabilities

Healthcare professionals have been slow to move to the cloud because of security considerations and the regulatory pressure to maintain utmost secrecy of patient data. But cloud providers have also started recruiting experts in the field to better understand the requirement and create the capability.

In Amazon’s case, AWS has been built up to meet the requirements of the Health Insurance Portability and Accountability Act, or HIPAA. Earlier this year, it also created a secret team called 1492 to work on healthcare-related technology. The goal of the team is to build solutions that will facilitate interoperability between different EHR systems including the migration of data from one system to another to make data more accessible to both physicians and patients.

Cerner Has Significant Share Of Fragmented EHR Market

According to the KLAS US Hospital EMR Market Share 2017 report, the EHR market is dominated by a few large players. According to the report, Epic with its 25.8% share, Cerner with its 24.6% share and Meditech with its 16.6% share were the largest players in 2016. According to Kalorama, Cerner has the leading market share, followed by McKesson (NYSE:MCK) and then Epic with the rest of the market comprising GE Healthcare, athenahealth, Intersystems, QSI/NextGen, Meditech, Greenway, eClinicalWorks and 600 smaller players. CNBC quotes the 2017 Black Book Research report to say that Cerner and Epic together dominate the population health management software market.

Conclusion

While the fight for healthcare technology dollars is on and companies like Amazon, Microsoft (NASDAQ:MSFT) , Alphabet (NASDAQ:GOOGL) and Apple (NASDAQ:AAPL) have targeted it in their own ways, EHR is a segment that Amazon appears to have taken a lead in. That’s not to say that the others won’t join in or catch up. But Amazon has an advantage because it has several offerings today, has a dedicated team leading the effort and access to customer healthcare data through medtech devices and non-prescription home tests it already sells. This could boost its healthcare-related machine learning to better serve customers.

Amazon currently has a Zacks Rank #3 (Hold) while Cerner has a Zacks Rank #4 (Sell). However, you can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Amazon shares are up 59.2% this year while Cerner shares are up 47.2%. Both have done remarkably well with respect to the S&P 500, which only appreciated 16.7%.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>



Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Alphabet Inc. (GOOGL): Free Stock Analysis Report

Cerner Corporation (CERN): Free Stock Analysis Report

Apple Inc. (AAPL): Free Stock Analysis Report

Microsoft Corporation (MSFT): Free Stock Analysis Report

Original post

Zacks Investment Research

Amazon On The Brink Of EHR Deal With Cerner
 

Related Articles

Amazon On The Brink Of EHR Deal With Cerner

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email